A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pranlukast | CAS 103177-37-3 - Request Quote

Picture of Pranlukast
SZ CAT No:SZ-P101001
CAS No
103177-37-3
Mol.F.
C27H23N5O4
Mol.Wt.
481.5
Inv. Status
In Stock
Rel. CAS No150821-03-7 (hemihydrate) ; 103180-28-5 (Sodium salt) ; 190249-94-6 (potassium salt) ; 190249-96-8 (calcium salt) ; 2649974-59-2 (hydrate)
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Pranlukast is chemically N-(4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide. Pranlukast is supplied with detailed characterization data compliant with regulatory guideline. Pranlukast can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pranlukast.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 103177-37-3

Purchase 103177-37-3

Order 103177-37-3

Enquire 103177-37-3

price of 103177-37-3

103177-37-3 Supplier

103177-37-3 Manufacturer

103177-37-3 Exporter

buy high quality Pranlukast

Purchase Pranlukast

Pranlukast suppliers

Pranlukast manufacturers

Pranlukast price

Order Pranlukast

Enquire Pranlukast

Pranlukast cost

Pranlukast Supplier

Pranlukast Distributor

Pranlukast for Method Validation

Pranlukast Reference Standard

Pranlukast for ANDA Filing

Pranlukast for Forced Degradation Studies

Pranlukast Identification Standards

Pranlukast for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,